Functional evidence that gastroprotection can be induced by activation of central α(2B)-adrenoceptor subtypes in the rat

K. Gyires, Katalin Müllner, A. Rónai

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Clonidine injected intracerebroventricularly (i.c.v.) (0.47 nmol/rat) exerted gastric mucosal protective effect against acidified ethanol. Evidence was obtained that the gastroprotective effect of clonidine was blocked by i.c.v. injected α2-adrenoceptor antagonists yohimbine (non-subtype selective antagonist), prazosin and 2-[2-(4-(O-methoxyphenyl)piperazin-1-yl)ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione (ARC-239) (representative α(2B/2C)-adrenoceptor blocking agents) and opioid receptor antagonists naloxone (a non-selective, moderately μ-opioid receptor preferring antagonist), naltrindole and naltriben δ-opioid receptor antagonists). The centrally injected naltrindole (0.5 nmol/rat) antagonised also the gastroprotective effect of clonidine - but not that of the δ-agonist [D-Ala2, D-Leu5]enkephalin - administered peripherally. The results suggest that central α(2B/2C)-adrenoceptor subtypes and opioid - particularly δ - receptors are likely to be involved in the gastric mucosal protective effect of clonidine. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)131-135
Number of pages5
JournalEuropean Journal of Pharmacology
Volume396
Issue number2-3
DOIs
Publication statusPublished - May 19 2000

Fingerprint

naltrindole
Clonidine
Adrenergic Receptors
Narcotic Antagonists
Stomach
Yohimbine
Prazosin
Opioid Receptors
Naloxone
Ethanol

Keywords

  • α(2B)-Adrenoceptor
  • Clonidine
  • Gastroprotection
  • Opioid receptor

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Functional evidence that gastroprotection can be induced by activation of central α(2B)-adrenoceptor subtypes in the rat. / Gyires, K.; Müllner, Katalin; Rónai, A.

In: European Journal of Pharmacology, Vol. 396, No. 2-3, 19.05.2000, p. 131-135.

Research output: Contribution to journalArticle

@article{28067bece8a447fbaa4ada3af2a2a277,
title = "Functional evidence that gastroprotection can be induced by activation of central α(2B)-adrenoceptor subtypes in the rat",
abstract = "Clonidine injected intracerebroventricularly (i.c.v.) (0.47 nmol/rat) exerted gastric mucosal protective effect against acidified ethanol. Evidence was obtained that the gastroprotective effect of clonidine was blocked by i.c.v. injected α2-adrenoceptor antagonists yohimbine (non-subtype selective antagonist), prazosin and 2-[2-(4-(O-methoxyphenyl)piperazin-1-yl)ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione (ARC-239) (representative α(2B/2C)-adrenoceptor blocking agents) and opioid receptor antagonists naloxone (a non-selective, moderately μ-opioid receptor preferring antagonist), naltrindole and naltriben δ-opioid receptor antagonists). The centrally injected naltrindole (0.5 nmol/rat) antagonised also the gastroprotective effect of clonidine - but not that of the δ-agonist [D-Ala2, D-Leu5]enkephalin - administered peripherally. The results suggest that central α(2B/2C)-adrenoceptor subtypes and opioid - particularly δ - receptors are likely to be involved in the gastric mucosal protective effect of clonidine. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "α(2B)-Adrenoceptor, Clonidine, Gastroprotection, Opioid receptor",
author = "K. Gyires and Katalin M{\"u}llner and A. R{\'o}nai",
year = "2000",
month = "5",
day = "19",
doi = "10.1016/S0014-2999(00)00231-4",
language = "English",
volume = "396",
pages = "131--135",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Functional evidence that gastroprotection can be induced by activation of central α(2B)-adrenoceptor subtypes in the rat

AU - Gyires, K.

AU - Müllner, Katalin

AU - Rónai, A.

PY - 2000/5/19

Y1 - 2000/5/19

N2 - Clonidine injected intracerebroventricularly (i.c.v.) (0.47 nmol/rat) exerted gastric mucosal protective effect against acidified ethanol. Evidence was obtained that the gastroprotective effect of clonidine was blocked by i.c.v. injected α2-adrenoceptor antagonists yohimbine (non-subtype selective antagonist), prazosin and 2-[2-(4-(O-methoxyphenyl)piperazin-1-yl)ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione (ARC-239) (representative α(2B/2C)-adrenoceptor blocking agents) and opioid receptor antagonists naloxone (a non-selective, moderately μ-opioid receptor preferring antagonist), naltrindole and naltriben δ-opioid receptor antagonists). The centrally injected naltrindole (0.5 nmol/rat) antagonised also the gastroprotective effect of clonidine - but not that of the δ-agonist [D-Ala2, D-Leu5]enkephalin - administered peripherally. The results suggest that central α(2B/2C)-adrenoceptor subtypes and opioid - particularly δ - receptors are likely to be involved in the gastric mucosal protective effect of clonidine. Copyright (C) 2000 Elsevier Science B.V.

AB - Clonidine injected intracerebroventricularly (i.c.v.) (0.47 nmol/rat) exerted gastric mucosal protective effect against acidified ethanol. Evidence was obtained that the gastroprotective effect of clonidine was blocked by i.c.v. injected α2-adrenoceptor antagonists yohimbine (non-subtype selective antagonist), prazosin and 2-[2-(4-(O-methoxyphenyl)piperazin-1-yl)ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolindione (ARC-239) (representative α(2B/2C)-adrenoceptor blocking agents) and opioid receptor antagonists naloxone (a non-selective, moderately μ-opioid receptor preferring antagonist), naltrindole and naltriben δ-opioid receptor antagonists). The centrally injected naltrindole (0.5 nmol/rat) antagonised also the gastroprotective effect of clonidine - but not that of the δ-agonist [D-Ala2, D-Leu5]enkephalin - administered peripherally. The results suggest that central α(2B/2C)-adrenoceptor subtypes and opioid - particularly δ - receptors are likely to be involved in the gastric mucosal protective effect of clonidine. Copyright (C) 2000 Elsevier Science B.V.

KW - α(2B)-Adrenoceptor

KW - Clonidine

KW - Gastroprotection

KW - Opioid receptor

UR - http://www.scopus.com/inward/record.url?scp=18144449110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144449110&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(00)00231-4

DO - 10.1016/S0014-2999(00)00231-4

M3 - Article

VL - 396

SP - 131

EP - 135

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -